-
(2R,3R,4S,5R)-2-{5-amino-7-methyl-2,6,7,9,11-pentaazatricyclo[6.3.1.04,12]dodeca-1(12),3,5,8,10-pentaen-2-yl}-5-(hydroxymethyl)oxolane-3,4-diol hydrate
-
ChemBase ID:
154508
-
Molecular Formular:
C13H18N6O5
-
Molecular Mass:
338.31922
-
Monoisotopic Mass:
338.13386771
-
SMILES and InChIs
SMILES:
Cn1c2c3c(cn(c3ncn2)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)c(n1)N.O
Canonical SMILES:
OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cc2c3c1ncnc3n(nc2N)C.O
InChI:
InChI=1S/C13H16N6O4.H2O/c1-18-11-7-5(10(14)17-18)2-19(12(7)16-4-15-11)13-9(22)8(21)6(3-20)23-13;/h2,4,6,8-9,13,20-22H,3H2,1H3,(H2,14,17);1H2/t6-,8-,9-,13-;/m1./s1
InChIKey:
SPGRLWCWHWRPHX-DOKXERMVSA-N
-
Cite this record
CBID:154508 http://www.chembase.cn/molecule-154508.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(2R,3R,4S,5R)-2-{5-amino-7-methyl-2,6,7,9,11-pentaazatricyclo[6.3.1.04,12]dodeca-1(12),3,5,8,10-pentaen-2-yl}-5-(hydroxymethyl)oxolane-3,4-diol hydrate
|
|
|
IUPAC Traditional name
|
(2R,3R,4S,5R)-2-{5-amino-7-methyl-2,6,7,9,11-pentaazatricyclo[6.3.1.04,12]dodeca-1(12),3,5,8,10-pentaen-2-yl}-5-(hydroxymethyl)oxolane-3,4-diol hydrate
|
|
|
Synonyms
|
API-2
|
Akt/PKB Signaling Inhibitor-2
|
Inhibitor V
|
NSC 154020
|
TCN
|
VD-0002
|
Triciribine hydrate
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
12.45568
|
H Acceptors
|
8
|
H Donor
|
4
|
LogD (pH = 5.5)
|
-4.271866
|
LogD (pH = 7.4)
|
-2.4411151
|
Log P
|
-1.4642601
|
Molar Refractivity
|
90.5553 cm3
|
Polarizability
|
30.775778 Å3
|
Polar Surface Area
|
144.47 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
T3830
|
Biochem/physiol Actions Triciribine is a highly selective Akt/PKB inhibitor, that selectively inhibits the cellular phosphorylation/activation of Akt1/2/3. |
PATENTS
PATENTS
PubChem Patent
Google Patent